About the Event
PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. In 2016, for the fifth year in a row, a record number of delegates participated in PEGS Europe, as more than 800 attendees from 36 countries convened in beautiful Lisbon, Portugal to discuss the latest advances in protein and antibody engineering. 38% of attendees were Scientists and another 25% were Executives or Directors. 21% of attendees were from Big Pharma, 51% from Biotech, and 18% from Academia. The 2017 event will feature:
"The best biologics technology meeting in Europe: a must-attend conference for novel biologics."
- Rakesh D., Ph.D., VP, R&D, MedImmune
"PEGS Europe and PEGS keep going from strength to strength. One week at a PEGS event can stimulate ideas for a whole year. The presentations were exceptional, covering an extraordinary array of antibody and antibody-alternative technologies. PEGS Europe is unparalleled in both scope and quality."
- Kevin R., Ph.D., Scientist, Wellcome Trust Sanger Institute
"Once more, PEGS Europe was an outstanding event with great science and a perfect setting for networking. Very nice combination of topics and speakers."
- Philipp M., Ph.D., Project Leader, Biomedicine, University Hospital of Basel
"PEGS Europe is a gem for protein engineers with depth and breadth in a stimulating and engaging environment! I am glad that I came all the way from California to be a part of it."
- Seung C., Ph.D., Associate Director, Cell Biology, Xencor, Inc.